Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy

Conditions:   Neoplasm Metastasis;   Sarcoma;   Neoplasms, Germ Cell and Embryonal;   MelanomaInterventions:   Drug: decitabine (DAC);   Drug: Tetrahydrouridine (THU);   Drug: CelecoxibSponsor:   National Cancer Institute (NCI)Recruiting - verified July 2016

Source: ClinicalTrials.gov - July 19, 2016 Category: Research Source Type: clinical trials